pharma · Asthma · Respiratory Syncytial Virus Infections
GSK Glaxo Smith
GlaxoSmithKline
GSK Glaxo Smith clinical programs — 86 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 637 r Aulnois, Saint Amand les Eaux, 59 59230, FR, SAINT-AMAND LES EAUX
- Employees
- 30
- Programs
- 205
- Drugs
- 194
- Patents
- 0
GSK Glaxo Smith projects
86 ClinicalTrials.gov programs sponsored by GSK Glaxo Smith.
GSK Glaxo Smith has 86 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Gepotidacin
GlaxoSmithKline
Urinary Tract Infections
1 trial -
Glipizide
GlaxoSmithKline
Atherosclerosis
1 trial -
Gynaecological follow-up
GlaxoSmithKline
Infections, Papillomavirus
1 trial -
H5N1 adjuvanted split virus vaccine (A/Vietnam/1194/2004 strain)
GlaxoSmithKline
Influenza
1 trial -
Hepatitis B adjuvanted vaccine
GlaxoSmithKline
Hepatitis B
1 trial -
Human rotavirus liquid vaccine
GlaxoSmithKline
Infections, Rotavirus
1 trial -
Infanrix hexa™
GlaxoSmithKline
Poliomyelitis
1 trial -
Infanrix-IPV+Hib™
GlaxoSmithKline
Acellular Pertussis
1 trial -
Influenza A (H5N1) Virus monovalent vaccine
GlaxoSmithKline
Influenza
1 trial -
Influenza vaccine GSK1562902A Formulation 1
GlaxoSmithKline
Influenza
1 trial -
Influenza vaccine GSK2321138A
GlaxoSmithKline
Influenza
1 trial -
Lapatinib
GlaxoSmithKline
Neoplasms, Head and Neck
1 trial -
MEPOLIZUMAB
GlaxoSmithKline
Hypereosinophilic syndrome (HES)
1 trial -
Mencevax ACWY
GlaxoSmithKline
Infections, Meningococcal
1 trial -
Meningococcal vaccine GSK134612
GlaxoSmithKline
Infections, Meningococcal
2 trials -
Nimenrix
GlaxoSmithKline
Infections, Meningococcal
1 trial -
Niraparib
GlaxoSmithKline
Neoplasms, Breast
1 trial -
Niraparib Placebo Tablets
GlaxoSmithKline
Neoplasms, Breast
1 trial -
Placebo
GlaxoSmithKline
Infections, Papillomavirus
1 trial -
Placebo for Bepirovirsen Solution for Injection 150 mg/mL
GlaxoSmithKline
Hepatitis B, Chronic
1 trial -
Placebo for Bepirovirsen Solution for Injection 150 mg/mL
GlaxoSmithKline
Hepatitis B, Chronic
1 trial -
RSV MAT
GlaxoSmithKline
Respiratory Syncytial Virus Infections
1 trial -
Rosiglitazone Extended Release 2mg
GlaxoSmithKline
Alzheimer's Disease
1 trial -
SB-497115-GR 12.5mg
GlaxoSmithKline
Chronic Idiopathic Thrombocytopenic Purpura
1 trial -
Salbutamol HFA-134a
GlaxoSmithKline
Asthma
1 trial -
Tafenoquine
GlaxoSmithKline
Malaria, Vivax
2 trials -
Tritanrix-HepB/Hib-MenAC
GlaxoSmithKline
Whole Cell Pertussis
1 trial -
Tritanrix™-HepB/Hiberix™ Kft.
GlaxoSmithKline
Whole Cell Pertussis
1 trial -
albiglutide + insulin glargine
GlaxoSmithKline
Diabetes Mellitus, Type 2
1 trial -
alosetron
GlaxoSmithKline
Irritable Colon
1 trial -
denosumab
GlaxoSmithKline
Osteoporosis, Postmenopausal
1 trial -
dutasteride 0.5mg once daily for 4 years
GlaxoSmithKline
Prostatic Hyperplasia
1 trial -
eltrombopag
GlaxoSmithKline
Hepatitis C, Chronic
1 trial -
eltrombopag
GlaxoSmithKline
Purpura, Thrombocytopaenic, Idiopathic
2 trials -
fluticasone furoate/vilanterol
GlaxoSmithKline
Pulmonary Disease, Chronic Obstructive
1 trial -
lamotrigine, 300 mg/day
GlaxoSmithKline
Epilepsy, Partial
1 trial -
lapatinib
GlaxoSmithKline
Neoplasms, Breast
1 trial -
placebo to match albiglutide
GlaxoSmithKline
Diabetes Mellitus, Type 2
1 trial
Frequently asked questions
How many clinical projects does GSK Glaxo Smith have?
86 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.